On Fibrinolysis in Reproduction

References

• Abildgaard U, Uszynski M. Separation and characterization of two fibrinolytic inhibitors from human placenta. Thrombos Diathes Haemorrh 1971; 25: 580
   Google Scholar
• Ablondi F B., Hagan J J., Philips M, De Renzo E C. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by & epsilon;-aminocaproic acid. Arch Biochem Biophys 1959; 82: 153
   PubMed Web of Science ®Google Scholar
• Albrechtsen O K. The fibrinolytic activity of human tissues. Brit J Haemat 1957a; 3: 284
   PubMed Web of Science ®Google Scholar
• Albrechtsen O K. Fibrinolytic activity of animal tissues. Acta Physiol Scand 1957b; 39: 284
   Google Scholar
• Albrechtsen O K. The fibrinolytic agents in saline extracts of human tissues. Scand J Clin Lab Invest 1958; 10: 91
   PubMed Web of Science ®Google Scholar
• Albrechtsen O K. Fibrinolytic activity in the organism. Acta Physiol Scand 1959; 47(Suppl. 165)
   Google Scholar
• Albrechtsen O K., Storm O, Claassen M. Fibrinolytic activity in some human body fluids. Scand J Clin Lab Invest 1958; 10: 310
   PubMed Web of Science ®Google Scholar
• Alkjaersig N, Fletcher A P., Sherry S. The activation of human plasminogen. I. Spontaneous activation in glycerol. J Biol Chem 1958; 233: 81
   Google Scholar
• Alkjaersig N, Fletcher A P., Sherry S. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase and streptokinase. J Biol Chem 1958; 233: 86
   PubMedGoogle Scholar
• Alkjaersig N, Fletcher A P., Sherry S. Epsilon;-aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem 1959; 234: 832
   PubMed Web of Science ®Google Scholar
• Andersson L. Studies on fibrinolysis in urinary tract disease and its treatment with epsilon-aminocaproic acid. Acta Chir Scand 1962, Suppl. 301
   Google Scholar
• Andersson L, Nilsson I M., Liedberg G, Nilsson L, Rybo G, Eriksson O, Granstrand B, Melander B. Antifibrinolytica. Vergleichende Untersuchungen von trans-4-(Aminomethyl)-cyclo-hexancarbonsaure, Aminocapronsäure und p-Aminomethylbenzoesäure. Arzneim Forsch (Drug Res) 1971; 21: 424
   Google Scholar
• Andersson L, Nilsson I M., Niléhn J-E, Hedner U, Granstrand B, Melander B. Experimental and clinical studies on AMCA, the anti-fibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haemat 1965; 2: 230
   PubMedGoogle Scholar
• Andersson L, Nilsson I M., Ølow B. Fibrinolytic activity in man during surgery. Thrombos Diathes Haemorrh 1962; 2: 391
   Google Scholar
• Aoki N, von Kaulla K N. The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. Amer J Clin Path 1971a; 55: 171
   Google Scholar
• Aoki N, von Kaulla K N. Dissimilarity of human vascular plasminogen activator and human urokinase. J Lab Clin Med 1971b; 78: 354
   PubMed Web of Science ®Google Scholar
• Aoki N, von Kaulla K N. Human serum plasminogen antiactivator: its distinction from antiplasmin. Amer J Physiol 1971c; 220: 1137
   Google Scholar
• Astrup T. A proteolytic inhibitor in lung tissue. 18th International Physiology Congress, Copenhagen. Abstracts 81. 1950
   Google Scholar
• Astrup T. Fibrinokinase. Acta Physiol Scand 1951; 24: 267
   PubMedGoogle Scholar
• Astrup T. Ox lung tissue as a proteolytic inhibitor. Acta Physiol Scand 1952; 26: 243
   PubMedGoogle Scholar
• Astrup T. Fibrinolysis in the organism. Blood 1956; 11: 781
   PubMed Web of Science ®Google Scholar
• Astrup T. Tissue activators of plasminogen. Fed Proc 1966; 25: 42
   PubMedGoogle Scholar
• Astrup T. Blood coagulation and fibrinolysis in tissue culture and tissue repair. Biochem Pharmacol Suppl, Pergamon, London 1968; 241
   Google Scholar
• Astrup T, Albrechtsen O K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand J Clin Lab Invest 1957; 9: 233
   PubMed Web of Science ®Google Scholar
• Astrup T, Beller F, Glas P, Rasmussen J. Fibrinolytic activity of the human uterine tube. Obstet Gynec 1965; 25: 853
   PubMed Web of Science ®Google Scholar
• Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem 1952; 40: 346
   PubMed Web of Science ®Google Scholar
• Astrup T, Permin P M. Fibrinolysis in the animal organism. Nature 1947; 159: 681
   PubMed Web of Science ®Google Scholar
• Astrup T, Sterndorff I. The plasminogen activator in animal tissue. Acta Physiol Scand 1956; 36: 250
   PubMedGoogle Scholar
• Auerswald W, Doleschel W. Critical evaluation of the fibrin plate method for estimating fibrinolytic enzymes and activation. Thrombos Diathes Haemorrh 1960; 5: 112
   Google Scholar
• Bachmann F, Fletcher A P., Alkjaersig N, Sherry S. Partial purification and properties of the plasminogen activator from pig heart. Biochemistry 1964; 3: 1578
   PubMed Web of Science ®Google Scholar
• Ball A P., Silver D, Day E D. Plasminogen-fibrinogen complex formation as a prelude to fibrinogenolysis. Thrombos Diathes Haemorrh 1971; 25: 114
   Google Scholar
• Balsamo J, Lilien J. Embryonic cell aggregation: kinetics and specificity of binding of enhancing factors. Proc Nat Acad Sci USA 1974; 71: 727
   Google Scholar
• Bang N U., Fletcher A P., Alkjaersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. III. Demonstration of abnormal clot structure by electron microscopy. J Clin Invest 1962; 41: 935
   PubMed Web of Science ®Google Scholar
• Barlow G H., Lazer L. Characterization of the plasminogen activator isolated from human embryo kidney cells: comparison with urokinase. Thrombosis Research 1972; 1: 201
   Google Scholar
• Barlow G H., Summaria L, Robbins K C. Molecular weight studies on human plasminogen at the microgram level. J Biol Chem 1969; 244: 1138
   Google Scholar
• Barnhart M, Riddle J M. Cellular localization of profibrinolysin (plasminogen). Blood 1963; 21: 306
   PubMedGoogle Scholar
• Barros E, Fujimoto M, Yanagimachi R. Failure of zona penetration of preincubation in a blood serum fraction. J Repr Fertil 1973; 35: 89
   Google Scholar
• Beller F K., Goessner W, Herrschlein J. Tissue activator of the fibrinolytic system in placental tissue. Obstet Gynec 1962; 20: 117
   Google Scholar
• Beller F K., Weiss G. The fibrinolytic enzyme system in cervical mucus. Fertil Steril 1966; 17: 654
   Google Scholar
• Bennett N B. Further studies on an inhibitor of plasminogen activation in human serum. Thrombos Diathes Haemorrh 1970; 23: 553
   PubMedGoogle Scholar
• Bennett N B., Ogston C M., Ogston D. Studies on the blood fibrinolytic enzyme following acute myocardial infarction. Clin Sci 1967; 32: 27
   Google Scholar
• Berg W, Korsan-Bengtsen K. Separation of human fibrinogen and plasminogen by means of gel filtration. Thrombos Diathes Haemorrh 1963; 9: 151
   PubMedGoogle Scholar
• Bernik M B., Kwaan H C. Origin of fibrinolytic activity in cultures of the human kidney. J Lab Clin Med 1967; 70: 650
   PubMed Web of Science ®Google Scholar
• Bernik M B., Kwaan H C. Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest 1969; 48: 1740
   PubMed Web of Science ®Google Scholar
• Biggs R, Macfarlane R G., Pilling J. Observations on fibrinolysis. Experimental activity produced by exercise or adrenaline. Lancet 1947; 1: 402
   PubMedGoogle Scholar
• Blandau R J. Observations on implantation in the rat and guinea pig. Anat Rec 1949; 104: 331
   Google Scholar
• Blatt W F., Zylber J, Gray J L., Jensen A. Mechanism of bovine and human plasminogen activation by human plasmin and streptokinase. Fed Proc 1960; 19: 60
   Google Scholar
• Bouma B N., Hedner U, Nilsson I M. Typing of fibrinogen degradation products in urine in various clinical disorders. Scand J Clin Lab Invest 1971; 27: 331
   PubMed Web of Science ®Google Scholar
• Brakman P. Bovine fibrinogen without detectable plasminogen. Anal Biochem 1965; 11: 149
   PubMedGoogle Scholar
• Brakman P. Fibrinolysis. A standardized fibrin plate method and a fibrinolytic assay of plasminogen. Scheltema & Holkema, Amsterdam 1967; 73
   Google Scholar
• Caffier P. Die proteolytische Fähigkeit von Ei und Eibett. Z Gynäk 1929; 53: 2410
   Google Scholar
• Carrel A. A method for the physiological study of tissues in vitro. J Exp Med 1923; 38: 407
   Google Scholar
• Cash J D., Allan A GE. The fibrinolytic response to moderate exercise and intravenous adrenaline in the same subjects. Brit J Haemat 1967; 13: 376
   PubMed Web of Science ®Google Scholar
• Celander D R., Guest M M. Profibrinolysin-free fibrinogen. Fed Proc 1960; 19: 60
   Google Scholar
• Christensen L R. Streptococcal fibrinolysis: a proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J Gen Physiol 1945; 28: 363
   PubMed Web of Science ®Google Scholar
• Clarke R L., Orando A, Cliffton E E. Induction of fibrinolysis by venous obstruction. Angiology 1960; 11: 367
   PubMedGoogle Scholar
• Collen D, Tytgat G N., Claeys H, Piessens R. Metabolism and distributions of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Brit J Haemat 1972; 22: 681
   PubMedGoogle Scholar
• Dastre A. Fibrinolyse dans le sang. Arch Physiol 1893; 5: 661
   Google Scholar
• Davies M C., Englert M E., De Renzo E C. Interaction of streptokinase and human plasminogen. J Biol Chem 1964; 239: 2651
   PubMedGoogle Scholar
• Deman J J., Bruyneel E A., Mareel M M. A study on the mechanism of intercellular adhesion. J Cell Biol 1974; 60: 641
   PubMed Web of Science ®Google Scholar
• Derechin M, Johnson P, Szuchet S. Further studies with human plasminogen. Biochem J 1962; 84: 336
   Google Scholar
• Ekelund H, Hedner U, Nilsson I M. Fibrinolysis in newborns. Acta Paediat Scand 1970; 59: 33
   PubMed Web of Science ®Google Scholar
• Enders A S. Electron microscopy of an early implantation stage, with a postulated mechanism of implantation. Devel Biol 1964; 10: 395
   Google Scholar
• Enders A C., Schlafke S. Cytological aspects of trophoblast uterine interaction in early implantation. Am J Anat 1959; 125: 1
   Google Scholar
• Enders A C., Schlafke S. A morphological analysis of the early implantation stages in the rat. Am J Anat 1967; 120: 185
   Google Scholar
• Eriksson S. Studies in α2-antitrypsin deficiency. Acta Med Scand 1965, Suppl. 432
   Google Scholar
• Fearnley G R. Fibrinolysis. Williams and Wilkins, Baltimore 1965; 45
   Google Scholar
• Fermi C. Die Wirkung der proteolytischen Enzyme auf die lebendige Zelle als Grund einer Theorie ülber die Selbstverdauung. Zbl Physiol 1895; 8: 657
   Google Scholar
• Fink E, Jaumann E, Fritz H, Ingrisch H, Werle E. Protease-Inhibitoren im menschlichen Spermaplasma Isolierung durch Affinitätschromatographie und Hemmverhalten. Hoppe-Seyler's Z Physiol Chemi 1971b; 352: 1591
   PubMedGoogle Scholar
• Fink E, Klein F, Hammer G, Müller-Bardoff G, Fritz H. Proceedings of the International Research Conferences on Proteinase Inhibitors. Berlin, 1971a; 225, Walter de Gruyter
   Google Scholar
• Finlayson J S. “Fibrinogen”, K Laki. Marcel Dekker, Inc., New York 1968; 53
   Google Scholar
• Finn C, Lawn A M. Transfer of cellular material between the uterine epithelium and trophoblast during the early stages of implantation. J Reprod Fertil 1968; 15: 333
   Google Scholar
• Fischer A. The application of soybean inhibitor in tissue cultivation. Science 1949; 109: 611
   Google Scholar
• Fletcher A P., Alkjaersig N, Sherry S. Pathogenesis of the haemorrhagic diathesis developing during “fibrinolytic” states. The significance of defective fibrin polymerization. J Clin Invest 1959; 39: 1005
   Google Scholar
• Fritz H, Fink E, Meister R, Klein G. Isolierung von Trypsininhibitoren und Trypsin-Plasmin-Inhibitoren aus den Samenblasen von Meerschweinchen. Hoppe-Seyler's Z Physiol Chem 1970; 351: 1344
   Google Scholar
• Fritz H, Förg-Brey B, Fink E, Meyer M, Schliessler H, Schirren C, Humanankrosin. Gerinnung und Eigenschaften. Z Physiol Chem 1972; 353: 1943
   Google Scholar
• Fritz H, Schleuning W. Biochemistry and clinical significance of the trypsin-like proteinase acrosin from boar and human spermatozoa. Proc 2nd Internat Res Conf. Bayer-Symp V “Proteinase Inhibitors”, H Fritz, H Tschesche, L J. Greene, E Truscheit. 1974; 118
   Google Scholar
• Gaddum P, Blandau R. Proteolytic reaction of mammalian spermatozoa on gelatin membranes. Science 1970; 170: 749
   Google Scholar
• Gaddum-Rosse P, Blandau R J. Comparative studies on the proteolysis of fixed gelatin membranes by mammalian sperm acrosomes. Am J Anat 1972; 134: 133
   PubMedGoogle Scholar
• Ganrot P O. Determination of α2-macroglobulin as trypsinprotein esterase. Clin Chim Acta 1966; 14: 493
   PubMed Web of Science ®Google Scholar
• Ganrot P O., Niléhn J-E. Competition between plasmin and thrombin for ou-macroglobulin. Clin Chim Acta 1967; 17: 511
   PubMed Web of Science ®Google Scholar
• Ganrot P O., Niléhn J-E. Immunochemical determination of human plasminogen. Clin Chim Acta 1968; 22: 335
   PubMed Web of Science ®Google Scholar
• Glas-Greenealt P, Beller F K., Astrup T. Comparative assays of tissue plasminogen activator in myometrium, cervix and fibromyomas of the human uterus. Am J Obstet Gynec 1971; 110: 721
   Google Scholar
• Groskopf W R., Hsieh B, Summaria L, Robbins K C. Studies on the active center of human plasmin. The serine and histidine residue. J Biol Chem 1969; 244: 359
   Google Scholar
• Haendle H, Fritz H, Trautschold I, Werle E. Uber einen hormonabhängigen Inhibitor für proteolytische Enzyme in männlichen accessorischen Gesehlechtsdrüsen und in sperma. Z Physiol Chem 1965; 343: 185
   PubMedGoogle Scholar
• Haendle H, Ingrisch H, Werle F. Uber einen neuen Trypsin-Chymotrypsin Inhibitor im Cervixsekret der Frau. Hoppe Seyler's Z Physiol Chem 1970; 351: 545
   PubMedGoogle Scholar
• Hagan J J., Ablondi F B., De Renzo E C. Purification and biochemical properties of human plasminogen. J Biol Chem 1960; 235: 1005
   PubMed Web of Science ®Google Scholar
• Halban J, Frankel O. Zur Biochemie der Uterusmucosa. Gynek Rundsich 1910; 4: 471
   Google Scholar
• Hammond I, Jr. Recovery and culture of tubal mouse ova. Nature 1949; 163: 28
   PubMed Web of Science ®Google Scholar
• Harpel P, Bang N U., Homburger F, Treger A. Plasminogen activator in mouse uterine fluid: Its suppression by estradiol and progesterone. Proc. Soc. Exp. Biol. Med. 1966; 122: 1192
   Google Scholar
• Hedner U. Studies on an inhibitor of plasminogen activation in human serum. Thrombos Diathes Haemorrh 1973; 30: 414
   PubMedGoogle Scholar
• Hedner U, Nilsson I M. Determination of plasminogen in human plasma by a casein method. Thrombos Diathes Haemorrh 1965; 14: 545
   PubMedGoogle Scholar
• Hedner U, Nilsson I M. Comparison between a direct and an indirect method for determing plasminogen. Thrombos Diathes Haemorrh 1971; 26: 289
   Google Scholar
• Heimburger N. Basic mechanism of action of streptokinase and urokinase. Thrombos Diathes Haemorrh 1971, Suppl. 47: 21
   Google Scholar
• Heimburger N, Schwick H G. Die Fibrinagar-Elektrophorese. 2. Mitteilung: Untersuchungen zum Wirkungsmechanismus der Streptokinase. Thrombos Diathes Hemorrh 1962; 7: 444
   PubMedGoogle Scholar
• Hirschhäuser C, Baudner S, Daume E. Immunologic identification of human seminal plasma protease inhibitors in cervical mucus. Fertil Steril 1972; 23(Nr 9)630
   Google Scholar
• Hirschhäuser C, Kionke M. Properties of a human seminal plasma inhibitor for trypsin. Fertil Steril 1971; 22(Nr 6)360
   Google Scholar
• Hirschhauser C, Kionke M, Daume E, Buchholz R. Trypsin inhibitors in the tract. Acta Endocrin 1971; 68: 413
   Google Scholar
• Hisazumi H. Studies on the fibrinolytic activity in human semen studied by gel filtration. Invest Urol 1970; 7(5)410
   Google Scholar
• Huggins C, Neal W. Coagulation and liquefaction of semen. J Exp Med 1942; 76: 527
   PubMedGoogle Scholar
• Hummel B W C, Buck F F., de Renzo E C. Interaction of streptokinase and human plasminogen. J Biol Chem 1966; 241: 3474
   PubMedGoogle Scholar
• Iatridis S G., Ferguson J H. Effect of physical exercise on blood clotting and fibrinolysis. J Appl Physiol 1963; 18: 337
   PubMed Web of Science ®Google Scholar
• Ingemanson B. A method of reducing the fibrinolytic activity of endometrium cells in plasma clot tissue culture. Experientia 1959; 15: 159
   PubMedGoogle Scholar
• Ingemanson-Nordqvist B, Källén B. On the use of fibrinolysin inhibitors in plasma clot tissue culture. Exp Cell Res 1961; 21: 232
   Google Scholar
• Ingrisch H, Haendle H, Werle E. Uber die Konzentration des Trypsin-Inhibitors im Sperma von Gesunden und andrologisch Kranken und über ihre Beziehung zu anderen Parametern des Spermas. Andrologie 1970; 2: 103
   Google Scholar
• Johnson A J., Kline D L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967–1968. Thrombos Diathes Haemorrh 1969b; 21: 259
   PubMedGoogle Scholar
• Johnson A J., Skoza L, Tse A O. Studies on plasmin inhibition and plasminogen activation and its inhibition. Thrombos Diathes Haemorrh 1969a, Suppl. 32: 105
   Google Scholar
• Kaplan M H. Nature and role of lytic factor in hemolytic streptococcal fibrinolysis. Proc Soc Exp Biol Med 1944; 57: 40
   Google Scholar
• v. Kaulla K N., Shettles L B. Relationship between human seminal fluid and the fibrinolytic ssytem. Proc Soc Exp Biol 1953; 83: 692
   Google Scholar
• Kawano T, Morimoto K, Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253
   PubMed Web of Science ®Google Scholar
• Kester R C. Plasminogen activator in the human prostate. J Clin Path 1969; 22: 442
   PubMed Web of Science ®Google Scholar
• Kirchner G, Hirshäuser G, Kionke M. Protease activity in rabbit uterine secretion 24 hours before implantation. J Reprod Fertil 1971; 27: 259
   PubMedGoogle Scholar
• Kline D L., Ts'ao C-H. Activation of human plasminogen by streptokinase in the absence of Sk-plasmin complex. Amer J Physiol 1971; 220: 440
   Google Scholar
• Kok P, Astrup T. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 1969; 8: 79
   PubMed Web of Science ®Google Scholar
• Kowalski E, Budzynski A, Kopec M, Murawski K. Dysproteinemia induced in vitro by plasmin digestion of fibrinogen. Blood 1960; 15: 164
   Google Scholar
• Kremer J. A simple sperm penetration test. Int J Fertil 1965; 10: 209
   PubMedGoogle Scholar
• Kucinski C S., Fletcher A P., Sherry S. Effect of urokinase antiserum on plasminogen activators: Demonstration of Immunologic dissimilarity between plasma plasminogen activator and urokinase. J Clin Invest 1968; 47: 1238
   Google Scholar
• Kunitz M, Northrop J H. Isolation from beef pancreas of crystalline trypsinogen, trypsin, a trypsin inhibitor, and in inhibitor-trypsin compound. J Gen Physiol 1936; 19: 991
   PubMedGoogle Scholar
• Kwaan H C., Albrechtsen O K. Histochemical study of fibrinolytic activity in the rat uterus in normal and hormonally induced estrus. Amer J Obstet Gynec 1966; 95: 468
   Google Scholar
• Kwaan H C., Astrup T. Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique. Lab Invest 1967; 17: 140
   PubMed Web of Science ®Google Scholar
• Källén B, Röhl L. The fibrinolytic activity of human hyperplastic prostatae studied in tissue culture. Acta Chir Scand 1959; 118: 240, 1960
   Google Scholar
• Lack C H., Ali Y S. Tissue activator of plasminogen. Nature 1964; 201: 1030
   Google Scholar
• Ladehoff A A. The content of plasminogen activator in the human urinary tract. Scand J Clin Lab Invest 1960; 12: 136
   Google Scholar
• Ladehoff A A., Rasmussen J. Fibrinolysis and thromboplastic activity in relation to hemorrhage in transvesical prostatectomy. Scand J Clin Lab Invest 1961; 13: 231
   PubMed Web of Science ®Google Scholar
• Larsson B, Liedholm P, Sjöberg N O., Åstedt B. Increased fibrinolytic activity in the endometrium of patients using copper-IUD. Contraception 1974; 9(5)531
   Google Scholar
• Larsson B, Liedholm P, Åstedt B. Influence of copper and plastic devicies on the fibrinolytic activity of the rat endometrium. 1975, In manuscript
   Google Scholar
• Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta Physiol Scand 1952; 27: 371
   Google Scholar
• Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45
   PubMed Web of Science ®Google Scholar
• Lauritsen O S. Urokinase inhibitor in human plasma. Scand J Clin Lab Invest 1968; 22: 314
   PubMed Web of Science ®Google Scholar
• Lauritsen O S. The fibrinolytic enzyme system and trypsin inhibitor as measured by the casein method. Danish Med Bull 1970; 17(Suppl. II)
   Google Scholar
• Lesuk A, Terminiello L, Traver J H. Crystalline human urokinase: some properties. Science 1965; 147: 880
   Google Scholar
• Lewis J H., Ferguson J H. Studies on a proteolytic enzyme system of the blood. I. Fibrinolysokinase activators for profibrinolysin. J Clin Invest 1950; 29: 1059
   PubMed Web of Science ®Google Scholar
• Liedholm P. 1975, Unpublished data
   Google Scholar
• Liedholm P, Åstedt B. 1975, Unpublished data
   Google Scholar
• Lipinski B, Wegrzynowicz Z, Budzynski A Z., Kopec M, Latallo Z S., Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos Diathes Haemorrh 1967; 17: 65
   PubMedGoogle Scholar
• Lundquist F, Thorsteinsson Th, Buus O. Purification and properties of some enzymes in human seminal plasma. Biochem J 1955; 59: 69
   PubMed Web of Science ®Google Scholar
• McConnel D, Johnson J G., Joung I, Holemans R. Localization of plasminogen activator activity in kidney tissue. Lab Invest 1966; 15: 980
   PubMed Web of Science ®Google Scholar
• Macfarlane R G. Fibrinolysis following operation. Lancet 1937; 1: 10
   Google Scholar
• Macfarlane R G., Biggs R. Observations on fibrinolysis. Spontaneous activity associated with surgical operations, trauma, etc. Lancet 1946; 11: 862
   Google Scholar
• McNicol G P., Gale S B., Douglas A S. In-vitro and in-vivo studies of a preparation of urokinase. Brit Med J 1963; 1: 909
   Google Scholar
• Mannucci P M., Åberg M, Robertson B, Nilsson I M. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Brit J Haemat 1975, (In press)
   Google Scholar
• Marder V J. Fibrinogen and fibrin degradation products. Physicochemical and physiological considerations. Thrombos Diathes Haemorrh 1971, Suppl. 47: 85
   Google Scholar
• Markwardt F, Klöcking H P., Landmann H. Vergleichende Untersuchungen über Antifibrinolytika. Thrombos Diathes Haemorrh 1967; 15: 561
   Google Scholar
• van Marie G, Liedholm P. 1975, Unpublished data
   Google Scholar
• Moghissi K S., Syner F N. The effect of seminal protease on sperm migration through cervical mucus. Int J Fertil 1970; 21: 43
   Google Scholar
• Mole R H. Fibrinolysin and the fluidity of the blood post mortem. J Path Bact 1948; 60: 413
   Google Scholar
• Morgan J F., Parker G. Use of antitrypsin agents in tissue culture. I. Crude soybean-inhibitor. Proc Soc Exp Biol Med 1949; 71: 665
   Google Scholar
• Mosesson M W. The preparation of human fibrinogen free of plasminogen. Biochim Biophys Acta 1962; 57: 204
   PubMedGoogle Scholar
• Moxley R T., Brakman P, Astrup T. Resting levels of fibrinolysis in blood in inactive and exercising men. J Appl Physiol 1970; 28: 549
   PubMed Web of Science ®Google Scholar
• Mtillertz S. Effect of carboxylic and amino acids on fibrinolysis produced by plasmin, plasminogen activator and proteases. Proc Soc Exp Biol Med 1954; 85: 326
   Google Scholar
• Miillertz S. Mechanism of activation and effect of plasmin in blood. Acta Physiol Scand 1956; 38(Suppl. 130)
   Google Scholar
• Nakahara M, Celander D R. Properties of microsomal activator of profibrinolysin found in bovine and porcine heart muscle. Thrombos Diathes Haemorrh 1968; 19: 482
   Google Scholar
• Nilehn J-E. Influence of split products of fibrinogen on results of blood coagulation tests and platelet adhesiveness. Scand J Haemat 1967a; 4: 430
   Google Scholar
• Nilehn J-E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thrombos Diathes Haemorrh 1967b; 18: 487
   PubMedGoogle Scholar
• Nilsson I M., Andersson L, Björkman S E. Epsilon-aminocaproic acid (EACA) as a therapeutic agent. Based on 5 year's clinical experience. Acta Med Scand 1966, Suppl. 448
   Google Scholar
• Nilsson I M., Krook H, Sternby N H., Söderberg E, Söderström N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 1961; 169: 323
   PubMed Web of Science ®Google Scholar
• Nilsson I M., Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thrombos Diathes Haemorrh 1962; 8: 297
   PubMedGoogle Scholar
• Nilsson I M., Pandolfi M. Fibrinolytic response of the vascular wall. Thrombos Diathes Haemorrh 1970, Suppl. 40: 231
   Google Scholar
• Nilsson I M., Pandolfi M, Robertson B. Properties of fibrinolytic activators appearing after venous stasis and intravenous injection of nicotinic acid. Coagulation 1970; 3: 13
   Google Scholar
• Nilsson I M., Sjoerdsma A, Waldenström J. Antifibrinolytic activity and metabolism of E-aminocaproic acid in man. Lancet 1960; 1: 1322
   PubMedGoogle Scholar
• Noordhoek Hegt V, Brakman P. Inhibition of fibrinolysis in human tissue as revelaed by a modified fibrin slide technique. IVth Intern Congr Thromb Haemostasis, Vienna, June, 19–221973
   Google Scholar
• Noordhoek Hegt V, Brakman P. Histochemical study of an inhibitor of fibrinolysis in the human arterial wall. Nature 1974; 248: 75
   PubMed Web of Science ®Google Scholar
• Norman P S., Hill B M. Studies on the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. J Exp Med 1958; 108: 639
   PubMed Web of Science ®Google Scholar
• Nussenzweig V, Seligmann M. Analyse par des méthodes immunochimiques, de la degradation par la plasmine du fibrinogène humain et de la fibrine, à difféYents stades. Rev Hémat 1960; 15: 451
   Google Scholar
• Nussenzweig V, Seligmann M, Pelmont J, Grabar P. Les produits de dégradation du fibrinogène humaine par la plasmine. Ann Inst Pasteur 1961; 100: 377
   PubMedGoogle Scholar
• Oettlé A G. Fibrinolytic factors in human semen. Proc Study Fertil 1950; 2: 71
   Google Scholar
• Okamoto S, Nagasawa S, Tagaki E, Tsukuda Y, Koyoi M, Sato M. Ref to British Patent Sepcification 1957; 770: 693
   Google Scholar
• Okamoto S, Okamoto U. Amino-metyl-cyclohexane-carboxylic acid. AMCHA. A new potent inhibitor of the fibrinolysis. Keio J Med 1962; 11: 105
   Google Scholar
• Oncley J L., Melin M, Richert D A., Cameron J W., Gross P M. The separation of the antibodies isoagglutinins, prothrombin, plasminogen and 6i-lipoprotein into subfractions of human plasma. J Amer Chem Soc 1959; 71: 541
   Google Scholar
• Opie E L. Enzymes and anti-enzymes of inflammatory exudates. J Exp Med 1905; 7: 316
   PubMedGoogle Scholar
• Owers N, Blandau R J. Enzymatic activities of impanting guinea pig embryos. Anat Rec 1968; 160: 404
   Google Scholar
• Painter R H., Charles A F. Characterization of a soluble plasminogen activator from kidney cell cultures. Amer J Physiol 1962; 202: 1125
   PubMedGoogle Scholar
• Pandolfi M. Persistence of fibrinolytic activity in fragments of human veins cultured in vitro. Thrombos Diathes Haemorrh 1970; 24: 43
   Google Scholar
• Pandolfi M. Histochemistry and assay of plasminogen activator(s). Europ J Clin Biol Res 1972; 17: 254
   PubMedGoogle Scholar
• Paraskevas M, Nilsson I M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
   PubMed Web of Science ®Google Scholar
• Phillips L L., Butler B C., Taylor H C. A study of cytofibrinokinase and fibrinolysin in extracts of tissue from human myometrium, endometrium, decidua, and placenta. Am J Obstet Gynec 1956; 71: 342
   PubMed Web of Science ®Google Scholar
• Ploug J, Kjeldgaard N O. Urokinase, an activator of plasminogen from human urine. I. Isolation and properties. Biochim Biophys Acta 1957; 24: 278
   PubMed Web of Science ®Google Scholar
• Polakoski K L., William W L. Studies on the purification and characterization of boar acrosin. Proc 2nd Intern Res Conf. Bayer-Symp V “Proteinase Inhibitors”. 1974, H Fritz, H Tschesche, L J. Greene, E Truscheil. 128
   Google Scholar
• Rasmussen J, Albrechtsen O K. Fibrinolytic activity in human seminal plasma. Fertil Steril 1960; 11: 264
   Google Scholar
• Rasmussen J, Albrechtsen O K. Fibrinolytic activity of rat uterine fluid. Specialia 1970; 841
   Google Scholar
• Rasmussen J, Albrechtsen O K., Astrup T. The fibrinolytic activity in the human prostate and seminal fluid. Europ J Haemat 1957; 494, Congr 6. Transactions
   Google Scholar
• Remmert L F., Cohen P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem 1949; 181: 431
   PubMed Web of Science ®Google Scholar
• de Renzo E C., Boggiano E, Hummel B CW. Interaction of streptokinase with human plasminogen and human plasmin. Fed Proc 1965; 24: 260
   Google Scholar
• Revel J P., Hoch P, Ho D. Adhesion of culture cells to their substratum. Exp Cell Res 1974; 84: 207
   PubMed Web of Science ®Google Scholar
• Rickli E E., Otavsky W I. New aspects of the activation of human plasminogen. IVth Intern Congr Thromb Haemostasis, Vienna, June, 19–221973
   Google Scholar
• Rimon A, Shamash Y, Shapiro B. The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin. J Biol Chem 1966; 241: 5102
   PubMed Web of Science ®Google Scholar
• Robbins K C., Summaria L. Purification of human plasminogen and plasmin by gel filtration on Sephadex and chromatography on diethylaminoethyl-Sephadex. J Biol Chem 1963; 238: 952
   Google Scholar
• Robbins K C., Summaria I. Biochemistry of fibrinolysis. Thrombos Diathes Haemorrh 1971, Suppl. 47: 9
   Google Scholar
• Robbins K C., Summaria L, Elwyn D, Barlow G H. Further studies on the purification and characterization of human plasminogen and plasmin. J Biol Chem 1965; 240: 541
   Google Scholar
• Robbins K C., Summaria L, Hsieh B, Shah R H. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J Biol Chem 1967; 242: 2333
   PubMed Web of Science ®Google Scholar
• Robertson B R. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis. Acta Chir Scand 1971; 137: 643
   Google Scholar
• Robertson B R., Nilsson I M., Nylander G. Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand 1970; 136: 173
   Google Scholar
• Rybo G. Plasminogen activators in the endometrium. Acta Obstet Gynec Scand 1966; 45: 429
   PubMed Web of Science ®Google Scholar
• Santesson L. Characteristics of epithelial mouse tumour cells in vitro and tumour structures in vivo. A comparative study. Acta Path Microbiol Scand 1935, Suppl. 24
   Google Scholar
• Schleuning W-D, Schiessler H, Fritz H. Highly purified acrosomal proteinase (boar acrosin): Isolation by affinity chromatography using bensamidine-cellulose and stabilization. Hoppe-Seyler's Z Physiol Chemi 1973; 354: 550
   Google Scholar
• Schliessler H, Arnhold M, Fritz H. Characterization of two proteinase inhibitors from human seminal plasma and spermatozoa. Proc 2nd Intern Res Conf. Bayer-Symp V “Proteinase Inhibitors”, H Fritz, H Tschesche, L J. Greene, E Truscheit. 1974; 147
   Google Scholar
• Schiessler F H., Schleuning W D. Proteinases and proteinase inhibitors in the fertilization process: New concepts of control. Adv Biosci 1973; 10: 271
   Google Scholar
• Schmidt-Mathiesen H. Afibrogenämie und fibrinolyse in der Geburtshilfe. Wesen, Bedeutung, Diagnose und Therapie. Landartz 1966; 42: 1047
   Google Scholar
• Schultze H E., Göllner I, Heide K, Schönenberger M, Schwick G. Zur Kenntnis der α-Globuline des menschlichen Normalserums. Z Naturforsch, 10b: 463
   Google Scholar
• Schultze H E., Heide K, Haupt H. a-i-antitrypsins aus Humanserum. Klin Wschr 1962; 40: 427
   PubMedGoogle Scholar
• Schultze H E., Heimburger N, Heide K, Haupt H, Störiko K, Schwick H G. (1963) Preparation and characterization of α1-antitrypsin inhibitor and α2-plasmin inhibitor of human serum. Proc 9th Congr Europ Soc Haemat, Lisbon, 1963. S. Karger, Basel/New York, 1315
   Google Scholar
• Schumacher G FB. Inhibition of rabbit sperm acrosomal protease by human alpha1-antitrypsin and other protease inhibitors. Contraception 1971; 4(Nr 2)67
   Google Scholar
• Schumacher G F B, Pearl M J. Alpha-antitrypsin in cervical mucus. Fertil Steril 1968; 19(No 1)91
   Google Scholar
• Schumacher G F B, Zaneveld L JD. Proteinase inhibitors inhuman cervical mucus and their in vitro interactions with human acrosin. Proc 2nd Intern Res Conf. Bayer-Symp V “Proteinase Inhibitors”., H Fritz, H Tschesche, L J. Greene, E Truscheit. 1974; 178
   Google Scholar
• Schonenberger M, Schmidtberger R, Schultze H E. Ueber das α2-macroglobulin. Z Naturforsch 1958; 13b: 761
   PubMedGoogle Scholar
• Shamashj Y, Rimon A. The plasmin inhibitors of plasma. I. A method for their estimation. Thrombos Diathes Haemorrh 1964; 12: 119
   Google Scholar
• Sherry S, Alkjaersig N, Fletcher A P. Activity of plasmin and streptokinase-activator on substituted arginine and lysine esters. Thrombos Diathes Haemorrh 1966; 16: 18
   Google Scholar
• Sherry S Y., Lindemeyer R I., Fletcher A P., Alkjaersig N. Studies on enhanced fibrinolytic activity in man. J Clin Invest 1959; 38: 810
   PubMed Web of Science ®Google Scholar
• Sjoerdsma A, Nilsson I M. Aliphatic amino compounds as inhibitors of plasminogen activation. Proc Soc Exp Biol Med 1960; 103: 533
   Google Scholar
• Stambaugh R, Buckley J. Zona pellucida dissolution enzymes of the rabbit sperm head. Science 1968; 160: 585
   Google Scholar
• Stambaugh R, Brackett B G., Mastroianni L. Inhibition of in vitro fertilization of rabbit ova by trypsin inhibitors. Biol Reprod 1969; 1: 223
   PubMedGoogle Scholar
• Stambaugh R, Smith M. Amino acid content of rabbit acrosomal proteinase and its similarity to human trypsin. Science 1974; 186: 745
   PubMed Web of Science ®Google Scholar
• Storm O. Fibrinolytic activity in human tears. Scand J Clin Lab Invest 1955; 7: 55
   PubMed Web of Science ®Google Scholar
• Sugiura H, Shimaya M. Histochemical findings of fibrinolytic activities in the prostatic gland. Invest Urol 1970; 8(2)188
   Google Scholar
• Summaria L, Arzadon A, Bernabe P, Robbins K, Barlow G H. Characterization of the NH2-terminal glutamic acid and NH2-terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods. J Biol Chem 1973; 248: 2984
   PubMedGoogle Scholar
• Summaria L, Hsieh B, Groskopf W R., Robbins K C. The isolation and characterization of the S-carboxymethyl β (light) chain derivative of human plasmin. The localization of the active site on the β(light) chain. J Biol Chem 1967b; 242: 5046
   Google Scholar
• Summaria L, Hsieh B, Robbins K C. The specific mechanism of activation of human plasminogen to plasmin. J Biol Chem 1967a; 242: 4279
   Google Scholar
• Suominen J J O, Niemi M. Human seminal trypsin inhibitors. J Reprod Fertil 1972; 29: 163
   Google Scholar
• Syner F N., Moghissi K S. Purification and properties of a human seminal proteinase. Biochem J 1972; 126: 1135
   PubMed Web of Science ®Google Scholar
• Tagnon H J., Palade G E. Activation of proplasmin by a factor from mammalian tissue. J Clin Invest 1950; 29: 317
   PubMed Web of Science ®Google Scholar
• Tagnon H J., Peterman M L. Activation of proplasmin by a tissue fraction. Proc Soc Exp Biol Med 1949; 70: 359
   PubMed Web of Science ®Google Scholar
• Takada A, Takada Y, Ambrus J L. Streptokinase-activatable proactivator of human and bovine plasminogen. J Biol Chem 1970; 245: 6389
   Google Scholar
• Takada A, Takada Y, Ambrus J L. Proactivators in the fibrinolysin system. Thrombos Diathes Haemorrh 1971, Suppl. 47: 37
   Google Scholar
• Todd A S. Histological localization of fibrinolysin activator. J Path Bact 1959; 78: 281
   PubMedGoogle Scholar
• Triantaphyllopoulos E, Triantaphyllopoulos D C. Variability of the anticoagulant of incubated fibrinogen. Amer J Physiol 1965; 208: 521
   PubMedGoogle Scholar
• Triantaphyllopoulos D C., Triantaphyllopoulos E, Chandra S. Effect of fibrin(ogen) degradation products on coagulation. Thrombos Diathes Haemorrh 1971, Suppl. 47: 121
   Google Scholar
• Tschesche H, Kupfer S, Lengel O, Klauser R. Purification, characterization and structural studies of proteinase inhibitors from boar seminal plasma and boar spermatozoa. Proc 2nd Intern Res Conf. Bayer-Symp V “Proteinase Inhibitors”, H Fritz, H Tschesche, L J. Greene, E Truscheit. 1974; 164
   Google Scholar
• Tympanidis K, Astrup T. Fibrinolytic activity of rat, rabbit and human sperm cells. Proc Soc Exp Biol Med 1968; 129: 179
   Google Scholar
• Vignal A, Blatrix Ch, Steinbuch M. Fibrinogen free of plasminogen as substrate for fibrinolytic assays. Nature 1962; 193: 693
   Google Scholar
• Waldschmidt M, Hoffmann B, Karg H. Untersuchungen über tryptische Enzymaktivität in Geschlechtssekreten von Bullen. Zuchthygiena 1966; 1: 15
   Google Scholar
• Wallén P. Plasmin degradation of fibrinogen. Scand J Haemat 1971, Suppl. 13: 3
   Google Scholar
• Wallén P, Bergström K. Purification of human plasminogen on DEAE-cellulose. Acta Chem Scand 1960; 14: 217
   Google Scholar
• Wallen P, Wiman B. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochem Biophys Acta 1972; 257: 122
   PubMedGoogle Scholar
• Walther P J., Steinman H M., Hill R L., McKee P A. Activation of human plasminogen by urokinase. J Biol Chem 1974; 249: 1173
   Google Scholar
• Weiss G, Beller F K. Tissue activator of the fibrinolytic enzyme in the female reproductive system. Obstet Gynec 1969; 34: 809
   Google Scholar
• White W F., Barlow G H., Mozen M M. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 1966; 5: 2160
   PubMed Web of Science ®Google Scholar
• Wiman B. Primary structure of peptides released during activation of human plasminogen by urokinase. Europ J Biochem 1973; 39: 1
   Google Scholar
• Wiman B, Wallén P. Activation of human plasminogen by an insoluble derivative of urokinase. Europ J Biochem 1973; 36: 25
   PubMedGoogle Scholar
• Yamane J. Kausal-analytische Studien über die Befruchtung des Kanincheneies. Die Isolierung der auf das Bizyloplasma auflösend wirken-den Substanzen aus den Spermatozoen. Cytologia 1935; 6: 474
   Google Scholar
• Yanagimachi R, Teichman R J. Cytochemical demonstration of acrosomal proteinase in mairmalian and arian spermatozoa by a silver proteinate method. Biol Reprod 1972; 6: 87
   Google Scholar
• Zaneveld L J D, Dragoje B M., Schumacher G FB. Acrosomal proteinase inhibitor of human spermatozoa. Science 1972b; 177: 702
   Google Scholar
• Zaneveld L J D, Polakoski K L., Robertson R T., Williams W L. Proc. Intern Res Conf “Proteinase Inhibitors”. Berlin-New York, 1971a, H Fritz, H Tschesche. 236, Walter de Gruyter
   Google Scholar
• Zaneveld L J D, Polakoski K L., Williams W L. Properties of a proteo-lytic enzyme from rabbit sperm acrosomes. Biol Reprod 1972a; 6: 30
   PubMed Web of Science ®Google Scholar
• Zaneveld L J D, Robertson R T., Kessler M, Williams W L. Inhibition of fertilization in vivo by pancreatic and seminal plasma trypsin inhibitors. J Reprod Fertil 1971b; 25: 387
   PubMedGoogle Scholar
• Zaneveld L J D, Schumacher G F B, Fritz H, Fink C, Jaumann E. Interaction of human sperm acrosomal proteinase with human seminal plasma proteinase inhibitors. J Reprod Fertil 1973; 32: 525
   PubMedGoogle Scholar
• Zaneveld L J D, Schumacher G F B, Tauber P F., Propping D. Proteinase inhibitors and proteinases of human semen. Proc 2nd Intern Res Conf. Bayer-Symp V “Proteinase Inhibitors”, H Fritz, H Tschesche, L J. Greene, E Truscheit. 1974; 136
   Google Scholar
• Zaneveld L J D, Srivastava P N., Williams W L. Relationship of a trypsin-like enzyme in rabbit spermatozoa to capacitation. J Reprod Fertil 1969; 20: 337
   Google Scholar
• Astedt B. Fibrinolytic inhibitors in human reproducental blood. Acta Obstet Gynec Scand 1974; 53: 227
   Web of Science ®Google Scholar
• Astedt B, Bladh B, Holmberg G, Liedholm P. Purification of plasminogen activator(s) from human plasma. 1975, In manuscript
   Google Scholar
• Astedt B, Pandolfi M. Ontogenesis of tissue plasminogen activator in the human. Thrombos Diathes Haemorrh 1971; 25: 469
   PubMedGoogle Scholar
• Åstedt B, Pandolfi M. On release and synthesis of fibrinolytic activators in human organ culture. Rev Europ Etudes Clin Biol 1972; 17: 261
   PubMedGoogle Scholar
• Åstedt B, Pandolfi M, Nilsson I M. Inhibitory effect of placenta on plasminogen activation in human organ culture. Proc Soc Exp Biol Med 1972; 139: 1421
   PubMed Web of Science ®Google Scholar